Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (55)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rollinson, S.
Right arrow Articles by Morgan, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rollinson, S.
Right arrow Articles by Morgan, G. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 1, 43-47, January 2000
© 2000 Oxford University Press


Molecular Epidemiology and Cancer Prevention

Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia

Sara Rollinson, Philippa Roddam, Eleanor Kane1, Eve Roman1, Ray Cartwright1, Andrew Jack and Gareth J. Morgan2

Department of Haematology, Institute of Pathology, University of Leeds, Leeds LS2 9JT and
1 Leukaemia Research Fund Centre for Clinical Epidemiology, 30 Hyde Terrace, Leeds LS9 2LN, UK

Polymorphisms within the phase II metabolizer enzymes GST T1, GST M1 and GST P1 affect the body's ability to detoxify a range of potential leukaemogens encountered in the environment. Using PCR, GST T1, GST M1 and GST P1 genotypes were determined in 557 adults with acute leukaemia and 952 age, sex and geographically matched controls. The strongest association with acute leukaemia was observed for the GST T1 null genotype, which occurred among 19% of cases and 14% of controls [odds ratio (OR) 1.45, 95% confidence interval (CI) 1.09–1.93]. A slightly higher proportion of cases (53%) than controls (49%) displayed the GST M1 null genotype, although the difference was not statistically significant (OR 1.22, 95% CI 0.98–1.52). No effect was observed for the GST P1 genotype and no interaction between the GST T1 and GST M1 genotypes was evident. Acute myeloid leukaemia (AML) was weakly associated with both GST T1 null (OR 1.32, 95% CI 0.97–1.79) and GST M1 null (OR 1.24, 95% CI 0.98–1.56), whereas acute lymphoblastic leukaemia (ALL) was associated with GST T1 null (OR 3.28, 95% CI 1.31–8.26). No associations between smoking and disease risk in relation to GST T1 and GST M1 polymorphic status were found.

Abbreviations: ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; CI, confidence interval; FAB, French-American-British classification; GST, glutathione S-transferase; GST M1, glutathione S-transferase M1; GST P1, glutathione S-transferase P1; GST T1, glutathione S-transferase T1; OR, odds ratio.

2 To whom correspondence should be addressed Email: patsjr{at}leeds.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
haematolHome page
P. Bolufer, M. Collado, E. Barragan, J. Cervera, M.-J. Calasanz, D. Colomer, J. Roman-Gomez, and M. A. Sanz
The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia
Haematologica, March 1, 2007; 92(3): 308 - 314.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Kanai, K. Takahashi, and H. Inoue
Three Distinct-Type Glutathione S-Transferases from Escherichia coli Important for Defense against Oxidative Stress
J. Biochem., November 1, 2006; 140(5): 703 - 711.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J.-Q. He, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford
Glutathione S-Transferase Variants and Their Interaction with Smoking on Lung Function
Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 388 - 394.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Rollinson, J. M. Allan, G. R. Law, P. L. Roddam, M. T. Smith, C. Skibola, A. G. Smith, M. S. Forrest, K. Sibley, R. Higuchi, et al.
High-Throughput Association Testing on DNA Pools to Identify Genetic Variants that Confer Susceptibility to Acute Myeloid Leukemia
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 795 - 800.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Seedhouse, R. Faulkner, N. Ashraf, E. Das-Gupta, and N. Russell
Polymorphisms in Genes Involved in Homologous Recombination Repair Interact to Increase the Risk of Developing Acute Myeloid Leukemia
Clin. Cancer Res., April 15, 2004; 10(8): 2675 - 2680.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. K. Dasgupta, P. J. Adamson, F. E. Davies, S. Rollinson, P. L. Roddam, A. J. Ashcroft, A. M. Dring, J. A. L. Fenton, J. A. Child, J. M. Allan, et al.
Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma
Blood, October 1, 2003; 102(7): 2345 - 2350.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Sibley, S. Rollinson, J. M. Allan, A. G. Smith, G. R. Law, P. L. Roddam, C. F. Skibola, M. T. Smith, and G. J. Morgan
Functional FAS Promoter Polymorphisms Are Associated with Increased Risk of Acute Myeloid Leukemia
Cancer Res., August 1, 2003; 63(15): 4327 - 4330.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Hohaus, G. Massini, F. D'Alo', F. Guidi, R. Putzulu, A. Scardocci, A. Rabi, A. L. Di Febo, M. T. Voso, and G. Leone
Association between Glutathione S-Transferase Genotypes and Hodgkin's Lymphoma Risk and Prognosis
Clin. Cancer Res., August 1, 2003; 9(9): 3435 - 3440.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rollinson, A. P. Levene, F. K. Mensah, P. L. Roddam, J. M. Allan, T. C. Diss, E. Roman, A. Jack, K. MacLennan, M. F. Dixon, et al.
Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity
Blood, August 1, 2003; 102(3): 1007 - 1011.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. T. Bowen, M. E. Frew, S. Rollinson, P. L. Roddam, A. Dring, M. T. Smith, S. E. Langabeer, and G. J. Morgan
CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication
Blood, April 1, 2003; 101(7): 2770 - 2774.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. T. Voso, F. D'Alo', R. Putzulu, L. Mele, A. Scardocci, P. Chiusolo, R. Latagliata, F. Lo-Coco, S. Rutella, L. Pagano, et al.
Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia
Blood, September 26, 2002; 100(8): 2703 - 2707.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Davies, S. Bhatia, J. A. Ross, W. R. Kiffmeyer, P. S. Gaynon, G. A. Radloff, L. L. Robison, and J. P. Perentesis
Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia
Blood, June 17, 2002; 100(1): 67 - 71.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Allan, C. P. Wild, S. Rollinson, E. V. Willett, A. V. Moorman, G. J. Dovey, P. L. Roddam, E. Roman, R. A. Cartwright, and G. J. Morgan
Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia
PNAS, September 5, 2001; (2001) 191211198.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. IZZOTTI, C. CARTIGLIA, J. LEWTAS, and S. DE FLORA
Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype
FASEB J, March 1, 2001; 15(3): 752 - 757.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. E. Davies, S. J. Rollinson, A. C. Rawstron, E. Roman, S. Richards, M. Drayson, J. A. Child, and G. J. Morgan
High-Producer Haplotypes of Tumor Necrosis Factor Alpha and Lymphotoxin Alpha Are Associated With an Increased Risk of Myeloma and Have an Improved Progression-Free Survival After Treatment
J. Clin. Oncol., August 15, 2000; 18(15): 2843 - 2851.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. M. Davies, L. L. Robison, J. D. Buckley, G. A. Radloff, J. A. Ross, and J. P. Perentesis
Glutathione S-Transferase Polymorphisms in Children with Myeloid Leukemia: A Children's Cancer Group Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 563 - 566.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. M. Allan, C. P. Wild, S. Rollinson, E. V. Willett, A. V. Moorman, G. J. Dovey, P. L. Roddam, E. Roman, R. A. Cartwright, and G. J. Morgan
Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia
PNAS, September 25, 2001; 98(20): 11592 - 11597.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.